Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ATCC

ATCC Receives Contract to Advance Industrial Biomanufacturing and Produce Synthetic Aviation Fuel Precursors
From ATCC
Via Business Wire
ATCC Secures OASIS+ Multi-Agency Contract Vehicle from GSA
From ATCC
Via Business Wire
ATCC Announces New Executive Leadership Appointments
From ATCC
Via Business Wire
ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
From ATCC
Via Business Wire
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
From ATCC
Via Business Wire
ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development
From ATCC
Via Business Wire
ATCC Receives Grant from NIH to Build New Biomanufacturing Suite at its Manassas Headquarters
From ATCC
Via Business Wire
ATCC Announces Award from NIAID to Support Preclinical Models of Infectious Diseases
From ATCC
Via Business Wire
ATCC Receives Grant from Commonwealth’s Development Opportunity Fund to Apply Toward Its New Biomanufacturing Suite in Virginia
From ATCC
Via Business Wire
ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases
From ATCC
Via Business Wire
ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research
From ATCC
Via Business Wire
ATCC and Tissue Dynamics Announce a Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
From ATCC
Via Business Wire
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
From ATCC
Via Business Wire
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
From ATCC
Via Business Wire
ATCC Announces Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Award from NIAID
From ATCC
Via Business Wire
ATCC Products to be Used in Microgravity Experiments on the International Space Station
From ATCC
Via Business Wire
ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Support Its Preclinical Services for Biopharmaceutical Product Development
From ATCC
Via Business Wire
ATCC Appoints Dr. Alfredo Molinolo to Its Board of Directors
From ATCC
Via Business Wire
ATCC Announces New Award from BARDA to Further Support its Medical Countermeasures Clinical Studies Network
From ATCC
Via Business Wire
ATCC and USP Enter Strategic Collaboration to Support Global Quality Production of Biologics
From ATCC
Via Business Wire
ATCC Announces Participation with Areté on IARPA Contract to Develop New Methods for Identifying Low-Dose Radiation Exposure
From ATCC
Via Business Wire
ATCC Announces New Immuno-oncology CAR-T Target Luciferase Reporter Cell Lines to Enable Discovery and Development of Immunotherapies
From ATCC
Via Business Wire
ATCC Announces New Award from the National Cancer Institute to Process Biomaterials for Cancer Research
From ATCC
Via Business Wire
ATCC Expands Leadership Team to Provide Vision and Growth Strategy
From ATCC
Via Business Wire
ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis
From ATCC
Via Business Wire
ATCC Announces Two Projects from the U.S. Department of Agriculture’s Chief Scientific In-House Research Agency, the Agricultural Research Service
From ATCC
Via Business Wire
ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN
From ATCC
Via Business Wire
ATCC Announces Award from National Cancer Institute to Provide Cancer Epidemiology Services to the Research Community
From ATCC
Via Business Wire
ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Develop Well-Characterized Challenge Material of BSL-3 and BSL-4 Viruses
From ATCC
Via Business Wire
ATCC Announces Awards from DTRA that Strengthen ATCC’s Antiviral Drug Discovery and Development Portfolio for Global Health and Biodefense
From ATCC
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.